Fig. 3From: Evaluation of PD-L1 and B7-H3 expression as a predictor of response to adjuvant chemotherapy in bladder cancerAssociation of B7-H3 expression with recurrence-free survival, cancer-specific survival, and overall survival. A Recurrence-free survival (RFS) in tumors with high and low/negative expression of B7-H3. B Cancer-specific survival (CSS) in tumors with high and low/negative expression of B7-H3. C Overall survival (OS) in tumors with high and low/negative expression of B7-H3Back to article page